In Alzheimer’s disease, hsa-miR-100–5p is known to regulate neuron survival by targeting the Mammalian Target of Rapamycin (mTOR) pathway, a central player in regulating many fundamental cell processes and a critical factor in tumor metabolism [68–70]. Here, MTOR is linked to early-onset autosomal dominant Alzheimer disease.